Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gotlib

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 15, 1993
Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervationW Wallace, S T Ahlers, J Gotlib, et al.
Transplantation Proceedings|December 19, 2015
Factors Affecting Attitude Toward Organ Donation Among Nursing Students in Warsaw, PolandM Mikla, A Rios, A Lopez-Navas, et al.
Leukemia|December 22, 2017
Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosisA Pardanani, J Gotlib, A W Roberts, et al.
Transplantation Proceedings|October 16, 2016
Knowledge of the Concept of Encephalic Death: Is This an Obstacle in the Acceptance of Donation and Transplantation of Organs Among Students of Nursing at the Medical University of Warsaw in Poland?M Mikla, A Rios, A Lopez-Navas, et al.
The EMBO Journal|December 1, 1989
Differential brain expression of the Alzheimer's amyloid precursor proteinJ P Anderson, L M Refolo, W Wallace, et al.
Leukemia|June 10, 2015
Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemiaM S Khodadoust, B Luo, B C Medeiros, et al.
Leukemia|May 15, 2009
Monoclonal antibodies against IREM-1: potential for targeted therapy of AMLW Korver, X Zhao, S Singh, et al.
Leukemia|February 16, 2016
Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemiaI Alvarez-Twose, P Martínez-Barranco, J Gotlib, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Midostaurin: a magic bullet that blocks mast cell expansion and activationP Valent, C Akin, K Hartmann, et al.
Leukemia|August 31, 2007
Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and TreatmentG Barosi, R A Mesa, J Thiele, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|September 15, 1993
Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervationW Wallace, S T Ahlers, J Gotlib, et al.
Transplantation Proceedings|December 19, 2015
Factors Affecting Attitude Toward Organ Donation Among Nursing Students in Warsaw, PolandM Mikla, A Rios, A Lopez-Navas, et al.
Leukemia|December 22, 2017
Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosisA Pardanani, J Gotlib, A W Roberts, et al.
Transplantation Proceedings|October 16, 2016
Knowledge of the Concept of Encephalic Death: Is This an Obstacle in the Acceptance of Donation and Transplantation of Organs Among Students of Nursing at the Medical University of Warsaw in Poland?M Mikla, A Rios, A Lopez-Navas, et al.
The EMBO Journal|December 1, 1989
Differential brain expression of the Alzheimer's amyloid precursor proteinJ P Anderson, L M Refolo, W Wallace, et al.
Leukemia|June 10, 2015
Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemiaM S Khodadoust, B Luo, B C Medeiros, et al.
Leukemia|May 15, 2009
Monoclonal antibodies against IREM-1: potential for targeted therapy of AMLW Korver, X Zhao, S Singh, et al.
Leukemia|February 16, 2016
Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemiaI Alvarez-Twose, P Martínez-Barranco, J Gotlib, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Midostaurin: a magic bullet that blocks mast cell expansion and activationP Valent, C Akin, K Hartmann, et al.
Leukemia|August 31, 2007
Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and TreatmentG Barosi, R A Mesa, J Thiele, et al.
Pageof 3